One of the biggest pharma trade shows in Europe kicks off at the end of October

This issue marks The Medicine Maker's third birthday!

Can cell and gene therapies paint a picture of perfect future health?

Sustainable contracts and more subtle efforts can also go a long way to helping others worldwide.

Beyond developing medicines, what is the pharma industry doing to help make the world a better place?

In 100 years, medicine is likely to be vastly different to what we can predict – or even imagine.

Patheon's Steve Lam shares his lessons learned over three decades in bioprocessing.

Pfizer researchers share the story behind the first JAK inhibitor for rheumatoid arthritis

Neil Mahapatra gives the story behind a partnership with Oxford University to develop cannabinoid medicines

What's causing pharma's fascination with cannabinoids and cannabis?